Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

As this case continues, mifepristone remains on the market and FDA-approved 

NEW YORK, NY – Today, the U.S. Supreme Court heard oral arguments in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, a politically motivated lawsuit that challenges the FDA’s approval of mifepristone, a safe and effective drug commonly used for abortion. The case was brought by the anti-abortion movement to jeopardize the FDA’s credibility and further restrict access to abortion nationwide. The Supreme Court is expected to issue a decision in the case by late June. Mifepristone remains on the market and is FDA-approved. 

Statement from Wendy Stark, President & CEO, Planned Parenthood of Greater New York: 

Today, the U.S. Supreme Court heard oral arguments in another baseless lawsuit aimed at rolling back the clock to equitable access to mifepristone - a safe, effective, and decades-long approved abortion medication. This is not just another legal fight: It's a politically motivated effort to control our lives, our health, and our futures. Planned Parenthood of Greater New York calls on the Court to protect our ability to make our own medical decisions and preserve access to reproductive health care — something that is under dire threat in this country. Mifepristone, like abortion, is essential health care.

Important facts about mifepristone and the impact of this case: 

  • Mifepristone is safe, effective, and has been used by more than 5 million people in the United States for abortion and miscarriage care. 

  • Mifepristone has been FDA-approved for more than 23 years and is one of two medications most commonly used in medication abortion in the United States. 

  • Mifepristone will remain accessible without any potential medically unnecessary restrictions from the courts in states where abortion is legal at least until the Supreme Court rules on this case. 

  • Abortion bans and restrictions continue to do the most harm to Black, Latino, and Indigenous communities, rural communities, LGBTQ+ people, and young people — those who already face barriers to sexual and reproductive health care due to systemic racism and the resulting health inequities. 

  • The consequences of challenging the use of Mifepristone go far beyond abortion care — it could stifle medical innovation, upend the country’s drug approval process, and put every approved medication in the political crosshairs. 

*** 

About Planned Parenthood of Greater New York:    

Planned Parenthood of Greater New York (PPGNY) is a leading provider, educator, and advocate of sexual and reproductive health care in New York State. PPGNY’s 23 health centers offer patients a wide range of services in-person and by telehealth. PPGNY is a trusted source of medically accurate, evidence-based information that empowers people to make informed decisions about their health and future. As a voice for reproductive freedom, PPGNY supports legislation and policies that ensure all New Yorkers have access to the full range of reproductive health services and education. 

Español

This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.